Administering Lactiplantibacillus plantatum LS/07 repressed the tumor frequency, accompanied by an increase in CD4+ T-cells in tumor tissue, reduction in the serum tumor necrosis factor-α concentration, and elevation in CD8+ T-cell number in tumor tissue but decreased blood CD8+ T-cell count [24]. This evidence concerns the gene CD8A and neoplasm.